World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
18593
World Ranking
19445
National Ranking
783

Francesco Bertolini publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Francesco Bertolini sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 379 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Francesco Bertolini D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Francesco Bertolini sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Francesco Bertolini is affiliated with the European Institute of Oncology in Italy and primarily conducts research within the fields of Medicine and Biochemistry, Genetics and Molecular Biology.

The scientist's work covers several subfields, including:

  • Oncology
  • Immunology
  • Molecular Biology
  • Genetics
  • Hematology

Research by Bertolini engages with a range of topics, with a particular focus on:

  • Immune Cell Function and Interaction
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Single-cell and spatial transcriptomics

Recent publications include:

  • "Archaeogenomic distinctiveness of the Isthmo-Colombian area" (2021, Cell)
  • "Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19" (2020, Blood)
  • "Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects" (2022, Cell Reports)
  • "Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer" (2020, Cancer Research)
  • "Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases" (2020, Journal of Thrombosis and Haemostasis)

Bertolini frequently collaborates with coauthors such as:

  • Paolo Falvo
  • Stefania Orecchioni
  • Alessandro Raveane
  • Giulia Mitola
  • Giovanna Talarico

The scientist's work has been published in several venues, with notable frequency in:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Cancers
  • Research Square

Best Publications

  • The multifaceted circulating endothelial cell in cancer: towards marker and target identification

    Francesco Bertolini;Yuval Shaked;Patrizia Mancuso;Robert S. Kerbel

  • Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

    Francesco Bertolini;Saki Paul;Patrizia Mancuso;Silvia Monestiroli

  • Circulating endothelial cells Biomarker of vascular disease

    Andrew D. Blann;Alexander Woywodt;Francesco Bertolini;Todd M. Bull

  • Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

    Patrizia Mancuso;Alessandra Burlini;Giancarlo Pruneri;Aron Goldhirsch

  • Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents

    Yuval Shaked;Erik Henke;Jeanine M.L. Roodhart;Patrizia Mancuso

  • Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

    Filiberto Belli;Alessandro Testori;Licia Rivoltini;Michele Maio

  • Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis

    Yuval Shaked;Francesco Bertolini;Shan Man;Michael S. Rogers

  • Angiogenesis in myelodysplastic syndromes.

    G Pruneri;F Bertolini;D Soligo;N Carboni

  • Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer

    Silvia Dellapasqua;Francesco Bertolini;Vincenzo Bagnardi;Elisabetta Campagnoli

  • Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity.

    Yuval Shaked;Urban Emmenegger;Urban Emmenegger;Shan Man;Shan Man;Dave Cervi;Dave Cervi

  • Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

    Patrizia Mancuso;Marco Colleoni;Marco Colleoni;Angelica Calleri;Angelica Calleri;Laura Orlando;Laura Orlando

  • CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

    Francesco Bertolini;Chiara Dell'Agnola;Patrizia Mancuso;Cristina Rabascio

  • Drug repurposing in oncology—patient and health systems opportunities

    Francesco Bertolini;Vikas P. Sukhatme;Gauthier Bouche

  • Locoregional recurrence risk after lipofilling in breast cancer patients

    J.Y. Petit;E. Botteri;V. Lohsiriwat;M. Rietjens

  • Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

    C Bengala;F Bertolini;N Malavasi;C Boni

  • Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

    Alice Agliano;Ines Martin-Padura;Patrizia Mancuso;Paola Marighetti

  • Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study

    J.Y. Petit;M. Rietjens;E. Botteri;N. Rotmensz

  • Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

    Silvia Monestiroli;Patrizia Mancuso;Alessandra Burlini;Giancarlo Pruneri

  • Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients

    Francesco Bertolini;Manuela Battaglia;Paolo Pedrazzoli;Gian Antonio Da Prada

  • In Vitro Assessment of the Quality of Stored Platelet Concentrates

    Scott Murphy;Paulo Rebulla;Francesco Bertolini;Stein Holme

Frequent Co-Authors

Giovanni Martinelli
Giovanni Martinelli University of Bologna
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Robert S. Kerbel
Robert S. Kerbel University of Toronto
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Giuseppe Viale
Giuseppe Viale University of Milan
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca
Aron Goldhirsch
Aron Goldhirsch European Institute of Oncology
Antonino Neri
Antonino Neri University of Milan
Marco Colleoni
Marco Colleoni European Institute of Oncology
Pier Giuseppe Pelicci
Pier Giuseppe Pelicci European Institute of Oncology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a range of related healthcare programs and career paths. For registered nurses aiming to advance their role and expand their scope, adn to fnp programs provide an effective bridge from associate-level training to becoming a Family Nurse Practitioner.

Those interested in public health, wellness, and preventative care might consider online nutrition degree programs. These flexible options prepare graduates for careers in nutrition, dietetics, and health coaching.

Healthcare professionals focused on administration and leadership can enhance their qualifications through online mha programs cahme accredited. These degrees are ideal for climbing the management ladder within hospitals and healthcare organizations.

Additionally, RNs who want to earn a bachelor’s degree without the traditional hands-on requirements can enroll in rn to bsn online without clinicals programs. This pathway offers greater accessibility for working nurses.

Each of these online programs provides unique opportunities to specialize, advance your career, and make an impact in the evolving healthcare sector.

Best Scientists Citing Francesco Bertolini

Trending Scientists

Recently Published Articles